CellaVision AB (LTS:0MR5)
kr 239.25 0 (0%) Market Cap: 5.77 Bil Enterprise Value: 5.67 Bil PE Ratio: 38.63 PB Ratio: 7.55 GF Score: 93/100

Q2 2019 CellaVision AB Earnings Call Transcript

Jul 16, 2019 / 09:00AM GMT
Operator

Ladies and gentlemen, welcome to the CellaVision Q2 Report 2019. Today, I am pleased to present CEO, Zlatko Rihter. (Operator Instructions) Please begin your meeting.

Zlatko Rihter;publ;President;CEO
CellaVision AB

()-&

Good morning, everybody. My name is Zlatko Rihter, CEO of CellaVision. Today with me, as usually, Maria Morin; and Magnus Blixt here from Lund. Partly cloudy weather, but hopefully, the summer will come sooner because it's close to summer vacations for us here.

Anyway, we're not here to discuss the weather. We're here to discuss the quarterly report, and let's move then to Slide 3. As usual, I'll give a little bit of a background and then we'll move into the numbers as we usually do.

So again, for those of you that haven't followed us that close, I mean, we are active within the field of blood -- hematology analysis, trying to digitalize case that's been done in the microscope for a long time. And as we usually say, it's that we cannot deliver the Holy Grail within med tech

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot